Related Experiment Video
Updated: Jul 2, 2025

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
Published on: July 7, 2020
AMXT-1501 targets membrane phospholipids against Gram-positive and -negative multidrug-resistant bacteria
Jinxin Zheng1, Xiaoju Liu1, Yanpeng Xiong1
1Department of Infectious Diseases and Shenzhen Key Lab of Endogenous Infection, Shenzhen Nanshan People's Hospital and the 6th Affiliated Hospital of Shenzhen University Medical School, Shenzhen, People's Republic of China.
Abstract:
The rapid proliferation of multidrug-resistant (MDR) bacterial pathogens poses a serious threat to healthcare worldwide. Carbapenem-resistant (CR) Enterobacteriaceae, which have near-universal resistance to available antimicrobials, represent a particularly concerning issue. Herein, we report the identification of AMXT-1501, a polyamine transport system inhibitor with antibacterial activity against Gram-positive and -negative MDR bacteria. We observed minimum inhibitory concentration (MIC)50/MIC90 values for AMXT-1501 in the range of 3.13-12.5 μM (2.24-8.93 μg /mL), including for methicillin-resistant Staphylococcus aureus (MRSA), CR Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. AMXT-1501 was more effective against MRSA and CR E. coli than vancomycin and tigecycline, respectively. Subinhibitory concentrations of AMXT-1501 reduced the biofilm formation of S. aureus and Enterococcus faecalis. Mechanistically, AMXT-1501 exposure damaged microbial membranes and increased membrane permeability and membrane potential by binding to cardiolipin (CL) and phosphatidylglycerol (PG). Importantly, AMXT-1501 pressure did not induce resistance readily in the tested pathogens.
Insights
A novel polyamine transport system inhibitor, AMXT-1501, shows broad-spectrum antibacterial activity against multidrug-resistant (MDR) bacteria, including Gram-positive and Gram-negative pathogens. This compound effectively reduces bacterial growth and biofilm formation without readily inducing resistance.
Area of Science:
- Microbiology
- Infectious Diseases
- Drug Discovery
Background:
- Multidrug-resistant (MDR) bacterial pathogens, particularly carbapenem-resistant (CR) Enterobacteriaceae, present a significant global health threat due to limited treatment options.
- The emergence of resistance necessitates the development of novel antimicrobial agents with unique mechanisms of action.
Purpose of the Study:
- To identify and characterize AMXT-1501, a novel polyamine transport system inhibitor, for its antibacterial potential against MDR pathogens.
- To evaluate the efficacy, mechanism of action, and resistance potential of AMXT-1501.
Main Methods:
- Minimum inhibitory concentrations (MICs) were determined for AMXT-1501 against a panel of Gram-positive and Gram-negative MDR bacteria.
- Comparative efficacy against methicillin-resistant Staphylococcus aureus (MRSA) and CR Escherichia coli was assessed versus vancomycin and tigecycline.
- Biofilm formation assays were performed at subinhibitory concentrations.
- Microbial membrane integrity, permeability, and potential were analyzed upon AMXT-1501 exposure.
- Resistance development was evaluated under sustained exposure.
Main Results:
- AMXT-1501 demonstrated potent activity against MDR Gram-positive and -negative bacteria, with MIC50/MIC90 values ranging from 3.13–12.5 μM.
- The compound was more effective against MRSA and CR E. coli than vancomycin and tigecycline, respectively.
- Subinhibitory concentrations of AMXT-1501 inhibited biofilm formation in S. aureus and Enterococcus faecalis.
- AMXT-1501 induced microbial membrane damage, increased permeability and membrane potential by targeting cardiolipin and phosphatidylglycerol.
- No significant resistance was readily induced in tested pathogens.
Conclusions:
- AMXT-1501 is a promising novel antibacterial agent with broad-spectrum activity against challenging MDR pathogens.
- Its mechanism involves disruption of microbial membrane integrity and function.
- The low propensity for resistance development makes AMXT-1501 a valuable candidate for further therapeutic development.
More Related Videos
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
10:43Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
Published on: December 3, 2010
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...